Delivery Order SPE2DB22D3501-SPE2DB24FWV28
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp for the delivery of BREVIBLOC 2,000 MG/100 ML BAG 100ML. The contract, valued at $3,068.20, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. The contract has a firm fixed price pricing type and an ultimate completion date of August 16, 2024....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,156.27, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML medical supplies. The contract is a Firm Fixed Price Delivery Order that runs through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,737.03, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 15, 2023. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $5,057.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product, with a performance period through July 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025....
This federal contract award, valued at $2,289.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product, with a period of performance ending on September 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This is a $3,086.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The order is for 4,560,594,597 units of the pharmaceutical product BREVIBLOC 2,500 MG/250 ML BAG 250ML. This order is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product. The delivery order is valued at $9,995.45 and has a firm fixed price. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,398.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BREVIBLOC 100 MG/10 ML VIAL 10ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award to Amerisourcebergen Drug Corp for $1,507.42 is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen. This contract has no set-aside designation and is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. Amerisourcebergen, a prominent pharmaceutical distributor, has been awarded numerous federal contracts to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,365.78 Firm Fixed Price Delivery Order provides the DLA with 4566542930 - BRIDION 200 MG/2 ML VIAL 2ML, with a completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...